GabrielleMeyersMD

Oncology • Portland, OR

Assistant Professor, Medicine, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Meyers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyers' full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-5058

Education & Training

University of Utah HealthFellowship, Hematology and Medical Oncology, 2001 - 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1998 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1998

Certifications & Licensure

OR State Medical License 1999 - 2025
WA State Medical License 2022 - 2025
UT State Medical License 2001 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) Start of enrollment: 2011 Jun 01
Terminated
Phase 3
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Terminated
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques.
Helen L Wu, Whitney C Weber, Courtney M Waytashek, Carla D Boyle, Jason S Reed
Plos Pathogens. 2024-11-01
Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantati...
Gabrielle Meyers, Joseph Bubalo, Elizabeth Eckstrom, Katrina Winsnes, Paul A Carpenter
Transplantation and Cellular Therapy. 2024-07-01
Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience...
Hunter D Niehus, Jean Sabile, Richard T Maziarz, Gabrielle Meyers, Rachel Cook
Acta Haematologica. 2024-06-26

Abstracts/Posters

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
Gabrielle Meyers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Retrospect Reviews of PNH Tests with Long-Term Follow-up in a Single Institution
Gabrielle Meyers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Monkey Model Offers Clues for Potential Widespread HIV Cure in PeopleMay 25th, 2023
Research Offers Clues for Potential Widespread HIV Cure in People: New Study Reveals First Details on How Stem Cell Transplantation Can Kill Virus That Causes AIDSMay 25th, 2023
New Study Reveals First Details on How Stem Cell Transplant Can Kill Viruses That Cause AIDS – ScienceDailyJune 3rd, 2023